Dr. Beth Karlan, professor of obstetrics and gynecology in the David Geffen School of Medicine at UCLA and director of cancer populations at UCLA’s Jonsson Comprehensive Cancer Center, has been inducted into the 2019 class of Giants of Cancer Care in gynecologic malignancies by OncLive for her contributions to cancer research and clinical practice.
The recognition is bestowed annually by the oncology publication on health care professionals who have made advances in cancer treatment, diagnosis and research.
Giants of Cancer Care honors 15 researchers and educators who are nominated by members of the oncology community. The finalists are then selected by a seven-member advisory board of world-renowned oncologists.
“It’s an honor to receive this recognition,” said Karlan, who is also the vice chair of women’s health research in the obstetrics and gynecology department in the medical school. “For me, this award celebrates all the physicians and scientists who are working tirelessly to find better ways to prevent and eradicate deadly cancers.”
Karlan is renowned for her work in hereditary cancers and molecular drivers of ovarian cancer. She has identified subtyped-specific biomarkers for early detection, prognostication and personalized therapies. She is also active in studying inherited cancer risks due to genes like BRCA to better understand ovarian cancer etiology, improve prevention strategies and identify novel targets for prevention and treatment.
Past cancer center physicians who received the honor include Dr. Patricia Ganz, director of cancer prevention and control research at the cancer center and a distinguished professor in the UCLA Fielding School of Public Health, and Dr. Antoni Ribas, professor of medicine and director of the tumor immunology program at the cancer center.